市場調查報告書
商品編碼
1399739
脈搏血氧計市場規模(按產品類型、技術、年齡層、最終用途和預測),2022 年至 2030 年Pulse Oximeter Market Size By Product Type, By Technology, By Age Group, End-use & Forecast, 2022 - 2030 |
由於人們對呼吸健康監測的認知不斷提高,預計 2023 年至 2032 年脈搏血氧計市場規模的CAGR將超過 6.5%。該設備測量血液中的氧飽和度。易用性和非侵入性使醫療保健專業人員和個人都可以使用它們進行遠端監控。
此外,慢性呼吸道疾病(例如慢性阻塞性肺病(COPD)和氣喘)的流行也大大促進了產品的更廣泛採用。例如,全球氣喘網路編寫的《2022 年全球氣喘報告》顯示,印度約有 3,500 萬人患有氣喘。這些情況需要持續監測氧氣水平,脈搏血氧儀提供了一種方便、即時的方法來評估呼吸狀態。
全球脈搏血氧儀產業根據產品類型、技術、年齡層、最終用途和地區進行分類。
傳統技術領域預計到 2032 年將大幅成長,這得益於其可靠性和在各種醫療保健環境中的廣泛接受。儘管新技術不斷湧現,但使用既定的光吸收原理的傳統脈搏血氧儀仍然是測量血液中氧飽和度水平的值得信賴且經濟高效的方法。其簡單性和準確性使其成為首選,尤其是在難以獲得複雜替代方案的偏遠地區。
預計到 2032 年,家庭護理領域將為市場帶來高收入,這歸因於該設備能夠方便、主動地監測個人健康狀況。脈搏血氧儀已成為家庭使用的必備設備,特別是對於管理慢性呼吸系統疾病或監測整體健康狀況的人。脈搏血氧計的方便用戶使用性,加上攜帶式和以用戶為中心的設計的進步,將促進其在家庭護理環境中的採用。
歐洲脈搏血氧儀產業佔有率將在 2023 年至 2032 年間顯著成長,受到更容易患呼吸系統疾病的老齡化人口的青睞。完善的醫療基礎設施,加上積極主動的預防保健方法,為這些設備的採用創造了有利的環境。此外,嚴格的監管標準和對以患者為中心的醫療保健實踐的重視也有助於區域市場的成長。
Pulse Oximeter Market size is predicted to observe more than 6.5% CAGR from 2023 to 2032, driven by the rising awareness about respiratory health monitoring. The device measures oxygen saturation levels in the blood. The ease of use and non-invasive nature makes them accessible for both healthcare professionals and individuals for remote monitoring.
Additionally, the prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, has significantly contributed to the wider product adoption. For instance, The Global Asthma Report 2022, prepared by Global Asthma Network, revealed that approximately 35 million people suffered from asthma in India. These conditions need continuous monitoring of oxygen levels, and pulse oximeters provide a convenient and immediate way to assess respiratory status.
The global pulse oximeter industry is classified on the basis of product type, technology, age group, end-use, and region.
The conventional technology segment is anticipated to witness substantial growth through 2032, favored by its reliability and widespread acceptance in various healthcare settings. While newer technologies continue to emerge, the conventional pulse oximeter, using established principles of light absorption, remains a trusted and cost-effective method for measuring oxygen saturation levels in the blood. Its simplicity and accuracy make it a preferred choice, especially in remote areas where sophisticated alternatives are less accessible.
Homecare segment is estimated to generate high revenues for the market by 2032, attributed to the device's ability to monitor individuals' health conveniently and proactively. Pulse oximeters have become essential devices for at-home use, particularly for those managing chronic respiratory conditions or monitoring overall wellness. The user-friendly nature of pulse oximeters, coupled with advancements in portable and user-centric designs will bolster its adoption in homecare settings.
Europe pulse oximeter industry share will grow significantly between 2023 and 2032, favored by aging population who are more prone to respiratory conditions. Well-established healthcare infrastructure, coupled with a proactive approach to preventive care, fosters a conducive environment for the adoption of these devices. Moreover, stringent regulatory standards and the emphasis on patient-centric healthcare practices contribute to the regional market growth.